| Methods |
Random allocation (exact method and concealment not stated) |
| Participants |
Psoriatic arthritis (definition not stated)
N=120 |
| Interventions |
Salazopyrin 2g/day versus placebo |
| Outcomes |
Pain, patient global assessment, morning stiffness, Ritchie index, ESR, CRP
24 weeks duration |
| Notes |
Intention‐to‐treat analysis
2.5% dropout rate
3 variables available for inclusion after discussion with authors |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
Unclear risk |
B ‐ Unclear |
